Liver Cancer Diagnostics Market: The laboratory tests segment is anticipated to account for the largest market share

Cancer is defined as the abnormal growth of cells in the body. Cells located at any part of the body can turn cancerous and spread to other parts of the body.

Cancer is defined as the abnormal growth of cells in the body. Cells located at any part of the body can turn cancerous and spread to other parts of the body. Liver cancer begins in the cells of the liver. Several kinds of cancer can form in the liver. Hepatocellular carcinoma is considered to be the most common liver cancer and begins in the hepatocyte. Other types of liver cancer include hepatoblastoma and intrahepatic cholangiocarcinoma. These are considered to be less common. According to the American Society of Clinical Oncology (ASCO), around 80% of adult primary liver cancers are hepatocellular carcinomas. Liver cancer diagnostics include techniques used for liver cancer identification and confirmation.

Read Report Overview - https://www.transparencymarketresearch.com/liver-cancer-diagnostics-market.html

According to the World Cancer Research Fund, in 2018, nearly 840,000 new cases of liver cancer were diagnosed globally. Liver cancer is considered to be the fifth most common cancer among men and the ninth most common cancer among women. According to the Centers for Disease Control and Prevention (CDC), around 33,000 people are diagnosed with liver cancer in the U.S. every year, and about 26,000 people succumb to the disease. The percentage of people in the U.S. suffering from liver cancer has been increasing for several decades. According to the Department of Health in New York State, nearly 1,500 men and 600 women are diagnosed with liver cancer every year. Approximately 900 men and 500 women in New York succumb to liver cancer each year.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=61431

Rise in prevalence of liver cancer, high alcohol consumption, research & development activities including development of newer techniques for the diagnosis of liver cancer, availability of efficient cancer treatments, and rise in adoption of new techniques for detection of liver cancer are anticipated to boost the global liver cancer diagnostics market. However, the shortage of skilled professionals and lack of awareness about the technological advancements are expected to hamper the growth of the liver cancer diagnostics market.

Request for Analysis of COVID-19 Impact on Liver Cancer Diagnostics Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=61431

In terms of screening type, the global liver cancer diagnostics market can be segmented into laboratory tests, endoscopy, imaging, biopsy, and others. The laboratory tests segment can be bifurcated into biomarkers and blood tests. The laboratory tests segment is anticipated to account for the largest market share during the forecast period, attributed to increasing in a requirement for effective diagnostic tests for hepatocellular carcinoma. The biomarkers segment can be divided into molecular markers, oncofetal & glycoprotein antigens, pathological biomarkers, growth factors & receptors, and enzymes & isoenzymes. In terms of end-user, the liver cancer diagnostics market can be categorized into hospital associated laboratories, independent diagnostic laboratories, and others. The hospital associated laboratories segment is anticipated to account for the largest share of the global liver cancer diagnostics market, owing to an increase in the number and well-equipped infrastructure of hospitals.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=61431

In terms of region, the global liver cancer diagnostics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global liver cancer diagnostics market due to technological advancements, increase in demand for care diagnostics, and rapid adoption of novel diagnostics and therapeutic approaches. The liver cancer diagnostics market in the Asia Pacific is anticipated to witness strong growth, attributed to increases in population, a rise in prevalence of liver cancer, surge in initiatives by a government in health care, increase in research and development activities.

Pre Book Liver Cancer Diagnostics Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=61431&ltype=S

Key players operating in the global liver cancer diagnostics market are Illumina, Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., QIAGEN, Siemens Healthcare Private Limited, Danaher, Foundation Medicine, Inc., Biocept, Inc., Koninklijke Philips N.V., and Hologic, Inc. These players have adopted strategies such as partnerships, agreements, collaborations, partnerships, and new product development to gain a competitive advantage in the global liver cancer diagnostics market.

More Trending Reports by Transparency Market Research:

Tablet Coatings Market The increasing adoption of orphan drugs and the rising popularity of generics in the medical sector is a prime factor augmenting the growth of the global tablet coatings market. Tablet coating is the external covering of a tablet with a layer/substance. The coats utilized reach from the conventional glossing over to the current polymer and polysaccharides-based coats.

Medical Protective Equipment Market Medical protective equipment forms a core part of germ-protection measure adopted by healthcare workers in the treatment of infectious and communicable diseases. A range of products in the medical protective equipment market has garnered enormous attention among healthcare providers after the onset of Covid-19 pandemic. Personal protective equipment pieces such as gloves, masks, face shields, and googles have risen in adoption among healthcare workers (HCWs), patients, visitors in hospital settings to protect against transmission of infections from respiratory and body fluids.

Dental Bone Void Filler Market The rising quantity of synthetic goods is likely to contribute to the growth of the global dental bone void filler market in the near future. Tri-calcium phosphates as well as calcium sulphate are examples of synthetic fillers that have benefits such as a long shelf life and no danger of disease transmission. In surgical treatment, bone grafting has become a routine procedure. The global dental bone void filler market is growing as a result of the benefits of the substance.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Mr. Rohit Bhisey
Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/